Heroin Metabolism vs. Morphine Metabolism
Heroin undergoes rapid sequential deacetylation to 6-monoacetylmorphine (6-MAM) and then morphine, whereas morphine is directly metabolized via hepatic glucuronidation—this fundamental difference in metabolic pathways explains heroin's superior blood-brain barrier penetration and more rapid onset of effects. 1
Key Metabolic Differences
Heroin's Sequential Metabolism
- Heroin is hydrolyzed to both morphine and 6-monoacetylmorphine (6-MAM), a metabolite characterized by enhanced and rapid penetration of the blood-brain barrier 1
- The combined effect of morphine and 6-acetylmorphine metabolites is likely responsible for the high relative potency of heroin compared with other opioids 1
- Heroin is concomitantly rapidly metabolized and distributed among body tissues, with metabolic clearance of 2916 ± 321 mL/min that is largely extrahepatic and sixfold greater than hepatic blood flow 2
- After intravenous administration, heroin takes approximately 10 seconds to reach the brain due to its high lipid solubility 3
Morphine's Direct Metabolism
- The major pathway of morphine clearance is hepatic glucuronidation to morphine-3-glucuronide, which is pharmacologically inactive 4
- Morphine has a total plasma clearance ranging from 0.9 to 1.2 L/kg/h in postoperative patients 4
- Morphine-6-glucuronide, an active metabolite of morphine, contributes to analgesia and may worsen adverse effects as it accumulates in patients with renal insufficiency 5, 6
- The accepted elimination half-life of morphine in normal subjects is 1.5 to 2 hours 4
Pharmacokinetic Distinctions
Blood-Brain Barrier Penetration
- Heroin's high lipid solubility facilitates rapid absorption from the bloodstream and passage through the blood-brain barrier, whereas morphine has lower lipid solubility and slower CNS penetration 3
- When morphine is introduced outside of the CNS, plasma concentrations remain higher than corresponding CSF morphine levels due to the blood-brain barrier 4
- After heroin injection, 6-MAM reaches maximum concentration (Cmax) of 6.4 μM in extracellular fluid after 8 minutes, while heroin itself reaches Cmax of 1.2 μM after only 2 minutes 7
Active Metabolite Formation
- 6-MAM, not morphine, is responsible for the rapid neural effects and early dopamine release induced by intravenous heroin 8, 7
- Heroin is concomitantly metabolized almost equally to 6-MAM and morphine 2
- 6-MAM is then metabolized concomitantly to morphine and glucuronide conjugates in a 4:3 ratio 2
- Morphine administration alone, giving rise to morphine extracellular fluid concentrations similar to those observed shortly after 6-MAM injection, does not increase extracellular dopamine 7
Clinical Implications
Potency and Onset
- The terminal half-life of heroin is 60-90 minutes, resembling that of morphine, but is maintained by the rate-determining return of distributed heroin from esterase-free tissues 2
- The equianalgesic intravenous conversion ratio of morphine to diamorphine (heroin) is 2:1 9
- Heroin's large overall volume of distribution (344 ± 60 liters) is indicative of its wide distribution and lipophilicity 2
Renal Considerations
- Morphine, hydromorphone, and codeine should be used with caution in patients with fluctuating renal function because of the potential accumulation of renally cleared metabolites that may cause neurologic toxicity 6
- Normal renal clearances of heroin result in only 1.6 ± 0.2% of the dose being renally excreted unchanged 2
- The major excretion path of morphine conjugates is through the kidneys, with about 10% in the feces 4
Common Pitfalls
- Do not assume heroin is merely a prodrug for morphine—heroin per se and 6-MAM contribute significantly to the acute pharmacological effects, particularly the rapid onset and euphoric "rush" 10, 8, 7
- Factors influencing blood 6-MAM concentrations might change the behavioral effects of heroin, as 6-MAM is formed rapidly from heroin in blood and is the major substance reaching the brain after heroin administration 7
- Oral diacetylmorphine produces negligible plasma concentrations of both diacetylmorphine and 6-MAM, making it unlikely to produce a substantial "rush" and limiting its clinical utility 11